Human serum albumin (HSA) is a protein carrier in blood
transporting
metabolites and drugs. Glycated HSA (GHSA) acts as a potential biomarker
for diabetes. Thus, many attempts have been made to detect GHSA. Glycation
was reported to damage the structure and ligand binding capability,
where no molecular detail is available. Recently, the crystal structure
of GHSA has been solved, where two glucose isomers (pyranose/GLC and
open-chain/GLO) are located at Sudlow’s site I. GLO was found
to covalently bind to K195, while GLC is trapped by noncontact interactions.
GHSA exists in two forms (Schiff base (SCH) and Amadori (AMA) adducts),
but how both disrupt albumin activity microscopically remains unknown.
To this end, molecular dynamics simulations were performed here to
explore the nature of SCH and AMA. Both forms are found to alter the
main protein dynamics, resulting in (i) the widening of Sudlow’s
site I entrance, (ii) the size reduction of nine fatty acid-binding
pockets, (iii) the enlargement of Sudlow’s site I and the shrinking
of Sudlow’s site II, (iv) the enhancement of C34 reactivity,
and (v) the change in the W214 microenvironment. These unique characteristics
found here can be useful for understanding the effect of glycation
on the albumin function in more detail and designing specific and
selective GHSA detection strategies.